根治性治疗后头颈部鳞状细胞癌监测性18F-FDG PET/CT的诊断价值
该回顾性分析纳入739例接受根治性治疗的头颈部鳞状细胞癌(HNSCC)患者共2396次监测性FDG PET/CT扫描,评估其检测临床未预期复发或第二原发恶性肿瘤的诊断效能。结果显示敏感度97.9%、特异度98.9%、阳性预测值78.2%、阴性预测值99.9%、准确率98.8%,初诊IVA期及治疗后≥5年者复发发生率显著更高。
要点
- 监测性FDG PET/CT检测临床未预期复发或第二原发肿瘤的敏感度97.9%、特异度98.9%、准确率98.8%。
- 初诊IVA期患者复发发生率显著高于其他亚组(P=0.03),治疗后≥5年者亦显著更高(P<0.001)。
- 不同肿瘤部位、分期、治疗方式或治疗后时间的亚组间诊断效能无显著差异。
核心结论
- 监测性FDG PET/CT对根治性治疗后HNSCC患者临床未预期复发或第二原发恶性肿瘤的检测显示出优异的诊断效能。
- 作者认为监测频率和持续时间可根据初诊疾病分期进行调整,以优化早期发现和干预。
研究设计与样本
- 回顾性分析纳入739例接受根治性治疗的HNSCC连续患者,共2396次监测性FDG PET/CT扫描;监测性扫描定义为根治性治疗后无复发疑似的常规随访扫描。
- 基于敏感度、特异度、阳性预测值、阴性预测值和准确率评估FDG PET/CT的诊断效能。
主要发现
- 2396次监测性FDG PET/CT扫描中119次(5.0%)显示阳性发现,其中93次(78.1%)确认为真阳性。
- 真阳性检出包括局部区域转移、远处转移或第二原发恶性肿瘤。
- 敏感度97.9%、特异度98.9%、阳性预测值78.2%、阴性预测值99.9%、准确率98.8%。
- 初诊IVA期患者复发发生率显著高于其他亚组(P=0.03),治疗后≥5年者亦显著更高(P<0.001)。
- 按肿瘤部位、疾病分期、治疗方式或治疗后时间划分的亚组间诊断效能无显著差异。
临床怎么用
- 作者认为监测频率和持续时间可根据初诊疾病分期进行调整,以优化早期发现和干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to evaluate the diagnostic performance of surveillance FDG PET/CT for detection of clinically unexpected recurrent disease or second primary malignancy in head and neck squamous cell carcinoma (HNSCC) patients who underwent curative treatment. PATIENTS AND METHODS: We conducted a retrospective analysis of 739 consecutive patients with HNSCC who underwent 2396 surveillance FDG PET/CT scans. Surveillance FDG PET/CT scans were defined as routine follow-up scans after curative therapy without suspicion of recurrence. The diagnostic performance of FDG PET/CT was evaluated based on sensitivity, specificity, positive predictive value, negative predictive value, and accuracy. RESULTS: Of the 2396 surveillance FDG PET/CT scans, 119 (5.0%) showed positive findings, with 93 (78.1%) confirmed as true-positives. True-positive detections included locoregional metastases, distant metastases, or second primary malignancies. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 97.9%, 98.9%, 78.2%, 99.9%, and 98.8%, respectively. The incidence of recurrence was significantly greater in patients initially diagnosed with stage IVA disease (P = 0.03) and for which 5 or more years had elapsed since treatment (P < 0.001) than in other subgroups. However, no significant differences in diagnostic performance were observed across subgroups divided by tumor location, disease stage, treatment modality, or time since treatment. CONCLUSIONS: Surveillance FDG PET/CT showed excellent diagnostic performance for detection of clinically unexpected recurrent disease or second primary malignancies in patients with HNSCC after curative therapy. The frequency and duration of surveillance could be adjusted based on the initial disease stage to optimize early detection and intervention.
引用
- Whi W, Moon SH, Oh D, et al. Diagnostic Value of Surveillance 18F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma After Curative Therapy. Clin Nucl Med. 2024. PMID: 40029798. doi:10.1097/RLU.0000000000005639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。